GLORIA Study Team Receives 2026 German University Medicine Prize for Glioblastoma Research
TME Pharma said the GLORIA study team received the 2026 German University Medicine Prize for its glioblastoma research involving CXCL12 inhibitor NOX-A12.
Related stories
Dynacor Enters US$20 Million Gold Purchase and Prepayment Facility
Dynacor Group entered into an unsecured US$20 million gold purchase and prepayment facility with Auramet International.
M impact | EQUITY | Nov 03, 2026, 01:16 PM UTC
SK hynix Reports 9.1% Stake in Penguin Solutions, Gains Board Nomination Rights
SK hynix reported a 9.1% beneficial stake through preferred shares convertible into 6,096,103 common shares. SHIFTIX1 LLC bought the preferred shares on October 29, 2026, for $377.
M impact | EQUITY | Nov 03, 2026, 01:16 PM UTC
SBI Estimates Rs 19,500 Crore Post-Tax Impact From ECL Framework
State Bank of India has put its expected credit loss models in place, Chairman C S Setty said. The bank will absorb the estimated impact through a phased transition.
M impact | EQUITY | Nov 03, 2026, 01:16 PM UTC
CACI Wins Five-Year, $108 Million U.S. Air Force Contract
CACI said it was awarded a five-year, $108 million contract by the U.S. Air Force to advance financial transparency, operational efficiency and mission readiness.
M impact | EQUITY | Nov 03, 2026, 01:16 PM UTC
Rankin Acquires 41,350 Shares Outside the Marketplace
Rankin acquired 41,350 shares at SEK 235.15 on Nov. 3, 2026, outside the marketplace.
M impact | EQUITY | Nov 03, 2026, 01:16 PM UTC
Petrobras shares fall more than 3% in early trading
M impact | EQUITY | Nov 03, 2026, 01:15 PM UTC